Pediatrix Medical Group Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): May 09, 2024

 

 

 

 

 

 

Pediatrix Medical Group, Inc.

(Exact name of Registrant as Specified in Its Charter)

 

 

Florida			001-12111	26-3667538
(State or Other Jurisdiction of Incorporation)			(Commission File Number)	(IRS Employer Identification No.)
1301 Concord Terrace
Sunrise, Florida				33323
(Address of Principal Executive Offices)				(Zip Code)

 

Registrant’s Telephone Number, Including Area Code: 954 384-0175

 

(Former Name or Former Address, if Changed Since Last Report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
Common Stock, par value $.01 per share		MD		The New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

---

Item 5.07 Submission of Matters to a Vote of Security Holders.

On May 9, 2024, Pediatrix Medical Group, Inc., a Florida corporation ("the Company"), held its 2024 Annual Shareholders’ Meeting (the “Annual Meeting”). Of the 84,025,983 shares of common stock outstanding and entitled to vote, 77,537,611 shares were represented, constituting a quorum. The final results for each of the matters submitted to a vote of the Company’s shareholders at the Annual Meeting are as follows:

Proposal 1: All of the nominees for the Company’s Board of Directors were elected to serve until the Company’s 2025 Annual Shareholders’ Meeting or until their respective successors are elected and qualified, by the votes set forth in the table below:

 

 

Name		One Year				Against				Abstained				Broker Non-Vote
Laura A. Linynsky			73,432,501				1,509,624				43,525				2,551,961
Thomas A. McEachin			73,369,011				1,572,130				44,509				2,551,961
Mark S. Ordan			72,937,466				2,004,446				43,738				2,551,961
Michael A. Rucker			73,261,971				1,679,655				44,024				2,551,961
Guy P. Sansone			72,793,352				2,148,985				43,313				2,551,961
John M. Starcher, Jr.			73,449,095				1,492,773				43,782				2,551,961
James D. Swift, M.D.			74,088,894				862,285				34,471				2,551,961
Shirley A. Weis			72,600,050				2,343,090				42,510				2,551,961
Sylvia J. Young			73,458,297				1,484,944				42,409				2,551,961

 

 

Proposal 2: The appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the 2024 fiscal year was ratified by the Company’s shareholders, by the votes set forth in the table below:

 

For				Against				Abstained				Broker Non-Vote
	75,157,432				2,356,419				23,760				0

 

Proposal 3: The Company’s shareholders approved, on a non-binding, advisory basis, the compensation of the Company’s named executive officers for the 2023 fiscal year, by the votes set forth in the table below:

 

For				Against				Abstained				Broker Non-Vote
	71,662,763				3,286,998				35,889				2,551,961

 

 

 

 

---

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

			Pediatrix Medical Group, Inc.
Date:	May 9, 2024	By:	/s/ C. Marc Richards
			C. Marc Richards Chief Financial Officer

 

---